New Stock News | Shandong Linuo Pharmaceutical Packaging (301188.SZ) Files with the Hong Kong Stock Exchange
According to a disclosure by the Hong Kong Stock Exchange on September 28, Shandong Linuo Pharmaceutical Packaging Co., Ltd. (referred to as Linuo Pharmaceutical Packaging, 301188.SZ) has submitted an application for listing to the Main Board of the Hong Kong Stock Exchange, with China Merchants Securities International and Ligao Financial Group as its joint sponsors.
According to a disclosure by the Hong Kong Stock Exchange on September 28, Shandong Linuo Pharmaceutical Packaging Co., Ltd. (referred to as: Shandong Linuo Pharmaceutical Packaging, 301188.SZ) has submitted an application for listing to the Main Board of the Hong Kong Stock Exchange, with CMSC International and Ligao Financial Group as its joint sponsors. The prospectus shows that Shandong Linuo Pharmaceutical Packaging is a well-known borosilicate specialty glass supplier in China. The company focuses on the development, manufacturing, and sales of borosilicate pharmaceutical glass packaging and daily-use heat-resistant glass, with products applied in the pharmaceutical, biotechnology, food and beverage, and daily household industries. Leveraging the company's R&D capabilities in furnace design and glass melting technology, Shandong Linuo Pharmaceutical Packaging developed China's first hexagonal stepped all-electric glass melting furnace.
Related Articles

HK Stock Market Move | CHERY AUTO (09973) falls 5% intraday as lock-up shares are set to be released; exchange differences weighed on net profit in the first half.

HAITONG INT'L: Cuts LAOPU GOLD (06181) target price by 21% to HK$435, maintains "Outperform" rating.

CLSA: Contemporary Amperex Technology (03750) draws the most investor attention; maintain "High Conviction Outperform" rating.
HK Stock Market Move | CHERY AUTO (09973) falls 5% intraday as lock-up shares are set to be released; exchange differences weighed on net profit in the first half.

HAITONG INT'L: Cuts LAOPU GOLD (06181) target price by 21% to HK$435, maintains "Outperform" rating.

CLSA: Contemporary Amperex Technology (03750) draws the most investor attention; maintain "High Conviction Outperform" rating.






